BAJAJ BROKING

Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

540788

ASPIRA

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Aspira Pathlab & Diagnostics L Share Price Update

As of the latest trading session, Aspira Pathlab & Diagnostics L share price is currently at ₹ 67.66, which is up by ₹ 2.56 from its previous closing. Today, the stock has fluctuated between ₹ 61.85 and ₹ 68.00. Over the past year, Aspira Pathlab & Diagnostics L has achieved a return of 103.43 %. In the last month alone, the return has been -19.59 %. Read More...

Aspira Pathlab & Diagnostics L fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    69.60

  • P/E Ratio (TTM)

    79.39

  • Beta

    0.34

  • Book Value / share

    10.80

  • Return on equity

    0.00%

  • EPS (TTM)

    0.82

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.38

info icon alternate text

Aspira Pathlab & Diagnostics L Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 5.41
Operating Expense 5.12
Net Profit 0.38
Net Profit Margin (%) 7.02
Earnings Per Share (EPS) 0.37
EBITDA 0.86
Effective Tax Rate (%) 0.00
Particulars SEP 2024 (Values in Cr)
Revenue 6.18
Operating Expense 5.26
Net Profit 0.99
Net Profit Margin (%) 16.01
Earnings Per Share (EPS) 0.96
EBITDA 1.43
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 4.64
Operating Expense 4.74
Net Profit -0.02
Net Profit Margin (%) -0.43
Earnings Per Share (EPS) -0.02
EBITDA 0.44
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 3.82
Operating Expense 4.39
Net Profit -0.50
Net Profit Margin (%) -13.08
Earnings Per Share (EPS) -0.49
EBITDA -0.03
Effective Tax Rate (%) 0.00
Particulars DEC 2023 (Values in Cr)
Revenue 3.46
Operating Expense 4.31
Net Profit -0.74
Net Profit Margin (%) -21.38
Earnings Per Share (EPS) -0.72
EBITDA -0.27
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 13.20
Operating Expense 16.30
Net Profit -2.67
Net Profit Margin (%) -20.22
Earnings Per Share (EPS) -2.60
EBITDA -0.75
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 14.46
Operating Expense 14.87
Net Profit -0.09
Net Profit Margin (%) -0.62
Earnings Per Share (EPS) -0.09
EBITDA 1.92
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 19.54
Operating Expense 15.18
Net Profit 4.46
Net Profit Margin (%) 22.82
Earnings Per Share (EPS) 4.33
EBITDA 6.47
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 15.21
Operating Expense 14.03
Net Profit 1.38
Net Profit Margin (%) 9.07
Earnings Per Share (EPS) 1.45
EBITDA 3.71
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 8.42
Operating Expense 12.91
Net Profit -4.24
Net Profit Margin (%) -50.35
Earnings Per Share (EPS) -4.56
EBITDA -1.54
Effective Tax Rate (%) -0.71
Particulars MAR 2024 (Values in Cr)
Book Value / Share 5.07
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.16
EBITDA Margin -5.76
Particulars MAR 2023 (Values in Cr)
Book Value / Share 7.60
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.20
EBITDA Margin 13.28
Particulars MAR 2022 (Values in Cr)
Book Value / Share 7.64
ROE % 23.08
ROCE % 17.56
Total Debt to Total Equity 0.19
EBITDA Margin 33.11
Particulars MAR 2021 (Values in Cr)
Book Value / Share 3.29
ROE % 15.17
ROCE % 11.51
Total Debt to Total Equity 0.70
EBITDA Margin 24.46
Particulars MAR 2020 (Values in Cr)
Book Value / Share -1.21
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.47
EBITDA Margin -18.29
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.38
Total Assets 14.70
Total Liabilities 14.70
Total Equity 10.14
Share Outstanding 10293000
Price to Book Ratio 6.11
Return on Assets (%) -18.16
Return on Capital (%) -23.82
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.34
Total Assets 17.34
Total Liabilities 17.34
Total Equity 12.75
Share Outstanding 10293000
Price to Book Ratio 3.66
Return on Assets (%) -0.51
Return on Capital (%) -0.65
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.64
Total Assets 18.13
Total Liabilities 18.13
Total Equity 12.78
Share Outstanding 10293000
Price to Book Ratio 8.48
Return on Assets (%) 24.58
Return on Capital (%) 32.67
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.18
Total Assets 11.77
Total Liabilities 11.77
Total Equity 8.31
Share Outstanding 10293000
Price to Book Ratio 8.66
Return on Assets (%) 11.72
Return on Capital (%) 14.44
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.09
Total Assets 14.33
Total Liabilities 14.33
Total Equity 3.80
Share Outstanding 9293000
Price to Book Ratio -31.65
Return on Assets (%) -29.58
Return on Capital (%) -39.74
Particulars MAR 2024 (Values in Cr)
Net Income -2.67
Cash from Operations 1.05
Cash from Investing 0.13
Cash from Financing -0.95
Net change in Cash 0.23
Free Cash Flow 1.31
Particulars MAR 2023 (Values in Cr)
Net Income -0.08
Cash from Operations -0.01
Cash from Investing 0.15
Cash from Financing -0.93
Net change in Cash -0.78
Free Cash Flow 0.11
Particulars MAR 2022 (Values in Cr)
Net Income 4.45
Cash from Operations 2.03
Cash from Investing -0.51
Cash from Financing -1.35
Net change in Cash 0.16
Free Cash Flow 2.62
Particulars MAR 2021 (Values in Cr)
Net Income 1.38
Cash from Operations 5.67
Cash from Investing -0.09
Cash from Financing -2.17
Net change in Cash 3.40
Free Cash Flow 5.79
Particulars MAR 2020 (Values in Cr)
Net Income -4.24
Cash from Operations -1.83
Cash from Investing 0.24
Cash from Financing 1.27
Net change in Cash -0.35
Free Cash Flow -1.79
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6992.60 76.74 13.41 100542.86 5690.80 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 78.74 192.05 4.94 147.57 51.01 / 98.70
SHREE PACETRONIX LTD. 71.00 14.79 1.90 25.56 61.11 / 268.50
TRANSGENE BIOTEK LTD. 3.75 0.00 2.62 28.41 3.22 / 10.84
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6992.60 83.66 12.27 100542.86 5690.80 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 31.25 0.00 -16.74 23.34 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5584.95 29.60 6.27 6109.94 3750.00 / 6400.00

Aspira Pathlab & Diagnostics L Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
67.66 3.93 redarrow
red-green-graph indicator
9 Bearish
7 Bullish
  • 5 Days 66.50
  • 26 Days 71.60
  • 10 Days 67.40
  • 50 Days 73.10
  • 12 Days 67.90
  • 100 Days 70.00
  • 20 Days 70.30
  • 200 Days 61.30
66.20 PIVOT

First Support

64.40

First Resistance

67.79

Second Support

62.81

Second Resistance

69.59

Third Support

61.01

Third Resistance

71.18

RSI

38.54

ADX

14.02

MACD

-3.63

Williams % R

-48.41

Commodity Channel Index (CCI)

-61.10

Date

2025-04-29

Week

598.00

Same Day

1162.00

Month

2352.00

1 Year

0.35

3 Year

0.06

Over 1 Month

-19.59%

down

Over 1 Year

103.43%

down

Over 3 Months

-15.45%

down

Over 3 Years

9.93%

down

Over 6 Months

30.30%

down

Over 5 Years

12.26%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

Aspira Pathlab & Diagnostics L shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
81.6%
Promoter Holdings
18.39%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Deepali Arvind Bhanushali 885500.0 (8.6%) Shareholding of Promoter and Promoter Group
Arvind Karsandas Bhanushali 885500.0 (8.6%) Shareholding of Promoter and Promoter Group
Rinku Vinod Bhanushali 833500.0 (8.1%) Public Shareholding
Aditya Agrawal 760921.0 (7.39%) Public Shareholding
Rajesh Premji Bhanushali 567699.0 (5.52%) Public Shareholding
Vinod Pradhan Bhanushali 516000.0 (5.01%) Public Shareholding
Pankaj Jashwant Shah 500000.0 (4.86%) Public Shareholding
Pooja Rajesh Bhanushali 370269.0 (3.6%) Public Shareholding
Manas Modi 345345.0 (3.36%) Public Shareholding
Amit Modi 300849.0 (2.92%) Public Shareholding
Dhvani Vinod Bhanushali 300000.0 (2.91%) Public Shareholding
Vinod Pradhan Bhanushali Huf 300000.0 (2.91%) Public Shareholding
Amit Modi Huf 290387.0 (2.82%) Public Shareholding
Puspahas Agrawal 288268.0 (2.8%) Public Shareholding
Ram Awtar Ramsisaria 246715.0 (2.4%) Public Shareholding
Jay Arvind Bhanushali 228448.0 (2.22%) Public Shareholding
Nikunj Velji Mange 220158.0 (2.14%) Public Shareholding
Manoj Ramsisaria 205099.0 (1.99%) Public Shareholding
Shradha Ramsisaria 151566.0 (1.47%) Public Shareholding
Shraddha Jagdish Bhanushali 150262.0 (1.46%) Public Shareholding
Saakshi Gupta 144387.0 (1.4%) Public Shareholding
Devji Deyat Nanda 134638.0 (1.31%) Public Shareholding
Raj Arvind Bhanushali 77964.0 (0.76%) Shareholding of Promoter and Promoter Group
Paresh Bhanji Bhanushali 43999.0 (0.43%) Shareholding of Promoter and Promoter Group
Yashraj Biotechology Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Geeta Paresh Bhanushali 0.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

Aspira Pathlab & Diagnostics L corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

Aspira Pathlab & Diagnostics L Share Price

Aspira Pathlab & Diagnostics Limited (ASDL) was incorporated in July, 1973. ASDL is a leading pathology specialist, with Pan-India presence. It offer pathology and diagnostic services to individual patients, hospitals, other healthcare providers, and businesses. The Company, with a wider presence in Maharashtra India, enjoys a loyal customer base, that reflects on its strength as a brand, providing superior diagnostic testing and services.

Presently, Company is engaged into the business of running, owning, managing and administering Diagnostics Centers. Its principal activities consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai.

During the year, the Company commenced its business activities of diagnostic center & pathology from November 2016 onwards by acquiring running business activities of 'Ankur Pathology Laboratory'.

Aspira is focused on establishing itself as a strong regional player before scaling up its operations. Although, it follow an asset light model, other costs are significantly high. Most of these cost is front ended and the payback period is high. It is therefore working on building the right systems and optimize the cost. It is adopting new technologies that improve customer experience. Some of these are use of Chatbot, improving website, implementing patient engagement platform, Customer Service, etc. Also concentrating more on HLM, trying to expand area by targeting newly setup hospitals and laboratory and trying to achieve more technology and advancement.

Parent organization Indian Private
NSE symbol [-]
Founded 1973
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Aspira Pathlab & Diagnostics Ltd?

Answer Field

The share price of Aspira Pathlab & Diagnostics Ltd for NSE is ₹ 0.00 and for BSE is ₹ 67.66.

What is the Market Cap of Aspira Pathlab & Diagnostics Ltd?

Answer Field

The market cap of Aspira Pathlab & Diagnostics Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 69.60 Cr. as of now.

What is the 52 Week High and Low of Aspira Pathlab & Diagnostics Ltd?

Answer Field

The 52 Week High and Low of Aspira Pathlab & Diagnostics Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 106.78 and ₹ 25.00.

How to Buy Aspira Pathlab & Diagnostics Ltd share?

Answer Field

You can trade in Aspira Pathlab & Diagnostics Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Aspira Pathlab & Diagnostics Ltd?

Answer Field

The 1 year returns on the stock has been 103.43%.

What is the Current Share Price of Aspira Pathlab & Diagnostics Ltd?

Answer Field

Aspira Pathlab & Diagnostics Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 67.66 as on Apr 30 2025 03:22 PM.

What is the Market Cap of Aspira Pathlab & Diagnostics Ltd Share?

Answer Field

The market cap of Aspira Pathlab & Diagnostics Ltd for NSE ₹ 0.0 & for BSE ₹ 69.60 as on Apr 30 2025 03:22 PM.

What is the P/E Ratio of Aspira Pathlab & Diagnostics Ltd Share?

Answer Field

As on Apr 30 2025 03:22 PM the price-to-earnings (PE) ratio for Aspira Pathlab & Diagnostics Ltd share is 79.39.

What is the PB ratio of Aspira Pathlab & Diagnostics Ltd Share?

Answer Field

As on Apr 30 2025 03:22 PM, the price-to-book (PB) ratio for Aspira Pathlab & Diagnostics Ltd share is 10.80.

How to Buy Aspira Pathlab & Diagnostics Ltd Share?

Answer Field

You can trade in Aspira Pathlab & Diagnostics Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Aspira Pathlab & Diagnostics Ltd Share on Bajaj Broking App?

Answer Field

To buy Aspira Pathlab & Diagnostics Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Aspira Pathlab & Diagnostics Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|